Global Olanzapine Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Report Id

46787

Publisher Name

Global Info Research

Published Date

2/22/2019

No of Pages

122

Market Scenario

Olanzapine is an atypical antipsychotic drugs, it is suitable for schizophrenia and other severe positive symptoms (for example: delusions, hallucinations, thought disorder, hostility and suspicion) and / or negative symptoms (such as: apathy acute and maintenance treatment, emotional and social withdrawal, poverty of speech) psychosis. In this report, we research and analyze the olanzapine, which used for manufacturing the olanzapine tablets. Scope of the Report: In 2011, the Lilly’s patent protection expired that had undergone tremendous change of the olanzapine industry. More and more manufacturers had entered the industry leading to the fierce competition on the market. The value of sales of global olanzapine tablets dropped sharply in the past few years. At present, the United States is the largest producer and consumer of the olanzapine. Almost all of the olanzapine are used for manufacturing the olanzapine tablets products, most of the olanzapine producers manufacture the olanzapine for self-use, only few for export. Lilly is the largest producer and dominants the high-end field. The rest of manufacturers manufactures the generic olanzapine products, facing the low-end market, like Teva Pharmaceutical, Dr. Reddy's Laboratories, Apotex Inc, Mylan Pharmaceuticals, Par Pharmaceutical, Aurobindo Pharma, Torrent Pharmaceuticals, Jubilant Lifesciences, Sun Pharmaceutical, Sandoz, Hansoh Pharmaceutical, WATSON Pharmaceuticals and Zhejiang Langhua Pharmaceuticals etc. Canada India Israel and China play the important roles in the olanzapine market. But to the olanzapine tablets market, USA Japan and Europe are the most important consumers. The worldwide market for Olanzapine is expected to grow at a CAGR of roughly 2.3% over the next five years, will reach 210 million US$ in 2024, from 180 million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Olanzapine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Market Segment by Manufacturers, this report covers Lilly Teva Pharmaceutical Dr. Reddy's Laboratories Apotex Inc. Mylan Pharmaceuticals Par Pharmaceutical Aurobindo Pharma Torrent Pharmaceuticals Jubilant Lifesciences Sun Pharmaceutical Sandoz Hansoh Pharmaceutical WATSON Pharmaceuticals(Changzhou) Zhejiang Langhua Pharmaceuticals Market Segment by Regions, regional analysis covers North America (United States, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) Asia-Pacific (China, Japan, Korea, India and Southeast Asia) South America (Brazil, Argentina, Colombia etc.) Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Market Segment by Type, covers Patent Type Generics Type Market Segment by Applications, can be divided into Olanzapine Tablets Other Medicine The content of the study subjects, includes a total of 15 chapters: Chapter 1, to describe Olanzapine product scope, market overview, market opportunities, market driving force and market risks. Chapter 2, to profile the top manufacturers of Olanzapine, with price, sales, revenue and global market share of Olanzapine in 2017 and 2018. Chapter 3, the Olanzapine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast. Chapter 4, the Olanzapine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019. Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019. Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019. Chapter 12, Olanzapine market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024. Chapter 13, 14 and 15, to describe Olanzapine sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Table of Contents

Table of Contents 1 Market Overview 1.1 Olanzapine Introduction 1.2 Market Analysis by Type 1.2.1 Patent Type 1.2.2 Generics Type 1.3 Market Analysis by Applications 1.3.1 Olanzapine Tablets 1.3.2 Other Medicine 1.4 Market Analysis by Regions 1.4.1 North America (United States, Canada and Mexico) 1.4.1.1 United States Market States and Outlook (2014-2024) 1.4.1.2 Canada Market States and Outlook (2014-2024) 1.4.1.3 Mexico Market States and Outlook (2014-2024) 1.4.2 Europe (Germany, France, UK, Russia and Italy) 1.4.2.1 Germany Market States and Outlook (2014-2024) 1.4.2.2 France Market States and Outlook (2014-2024) 1.4.2.3 UK Market States and Outlook (2014-2024) 1.4.2.4 Russia Market States and Outlook (2014-2024) 1.4.2.5 Italy Market States and Outlook (2014-2024) 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) 1.4.3.1 China Market States and Outlook (2014-2024) 1.4.3.2 Japan Market States and Outlook (2014-2024) 1.4.3.3 Korea Market States and Outlook (2014-2024) 1.4.3.4 India Market States and Outlook (2014-2024) 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024) 1.4.4 South America, Middle East and Africa 1.4.4.1 Brazil Market States and Outlook (2014-2024) 1.4.4.2 Egypt Market States and Outlook (2014-2024) 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024) 1.4.4.4 South Africa Market States and Outlook (2014-2024) 1.4.4.5 Turkey Market States and Outlook (2014-2024) 1.5 Market Dynamics 1.5.1 Market Opportunities 1.5.2 Market Risk 1.5.3 Market Driving Force 2 Manufacturers Profiles 2.1 Lilly 2.1.1 Business Overview 2.1.2 Olanzapine Type and Applications 2.1.2.1 Product A 2.1.2.2 Product B 2.1.3 Lilly Olanzapine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.2 Teva Pharmaceutical 2.2.1 Business Overview 2.2.2 Olanzapine Type and Applications 2.2.2.1 Product A 2.2.2.2 Product B 2.2.3 Teva Pharmaceutical Olanzapine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.3 Dr. Reddy's Laboratories 2.3.1 Business Overview 2.3.2 Olanzapine Type and Applications 2.3.2.1 Product A 2.3.2.2 Product B 2.3.3 Dr. Reddy's Laboratories Olanzapine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.4 Apotex Inc. 2.4.1 Business Overview 2.4.2 Olanzapine Type and Applications 2.4.2.1 Product A 2.4.2.2 Product B 2.4.3 Apotex Inc. Olanzapine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.5 Mylan Pharmaceuticals 2.5.1 Business Overview 2.5.2 Olanzapine Type and Applications 2.5.2.1 Product A 2.5.2.2 Product B 2.5.3 Mylan Pharmaceuticals Olanzapine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.6 Par Pharmaceutical 2.6.1 Business Overview 2.6.2 Olanzapine Type and Applications 2.6.2.1 Product A 2.6.2.2 Product B 2.6.3 Par Pharmaceutical Olanzapine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.7 Aurobindo Pharma 2.7.1 Business Overview 2.7.2 Olanzapine Type and Applications 2.7.2.1 Product A 2.7.2.2 Product B 2.7.3 Aurobindo Pharma Olanzapine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.8 Torrent Pharmaceuticals 2.8.1 Business Overview 2.8.2 Olanzapine Type and Applications 2.8.2.1 Product A 2.8.2.2 Product B 2.8.3 Torrent Pharmaceuticals Olanzapine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.9 Jubilant Lifesciences 2.9.1 Business Overview 2.9.2 Olanzapine Type and Applications 2.9.2.1 Product A 2.9.2.2 Product B 2.9.3 Jubilant Lifesciences Olanzapine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.10 Sun Pharmaceutical 2.10.1 Business Overview 2.10.2 Olanzapine Type and Applications 2.10.2.1 Product A 2.10.2.2 Product B 2.10.3 Sun Pharmaceutical Olanzapine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.11 Sandoz 2.11.1 Business Overview 2.11.2 Olanzapine Type and Applications 2.11.2.1 Product A 2.11.2.2 Product B 2.11.3 Sandoz Olanzapine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.12 Hansoh Pharmaceutical 2.12.1 Business Overview 2.12.2 Olanzapine Type and Applications 2.12.2.1 Product A 2.12.2.2 Product B 2.12.3 Hansoh Pharmaceutical Olanzapine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.13 WATSON Pharmaceuticals(Changzhou) 2.13.1 Business Overview 2.13.2 Olanzapine Type and Applications 2.13.2.1 Product A 2.13.2.2 Product B 2.13.3 WATSON Pharmaceuticals(Changzhou) Olanzapine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.14 Zhejiang Langhua Pharmaceuticals 2.14.1 Business Overview 2.14.2 Olanzapine Type and Applications 2.14.2.1 Product A 2.14.2.2 Product B 2.14.3 Zhejiang Langhua Pharmaceuticals Olanzapine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 3 Global Olanzapine Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018) 3.1 Global Olanzapine Sales and Market Share by Manufacturer (2017-2018) 3.2 Global Olanzapine Revenue and Market Share by Manufacturer (2017-2018) 3.3 Market Concentration Rate 3.3.1 Top 3 Olanzapine Manufacturer Market Share in 2018 3.3.2 Top 6 Olanzapine Manufacturer Market Share in 2018 3.4 Market Competition Trend 4 Global Olanzapine Market Analysis by Regions 4.1 Global Olanzapine Sales, Revenue and Market Share by Regions 4.1.1 Global Olanzapine Sales and Market Share by Regions (2014-2019) 4.1.2 Global Olanzapine Revenue and Market Share by Regions (2014-2019) 4.2 North America Olanzapine Sales and Growth Rate (2014-2019) 4.3 Europe Olanzapine Sales and Growth Rate (2014-2019) 4.4 Asia-Pacific Olanzapine Sales and Growth Rate (2014-2019) 4.5 South America Olanzapine Sales and Growth Rate (2014-2019) 4.6 Middle East and Africa Olanzapine Sales and Growth Rate (2014-2019) 5 North America Olanzapine by Country 5.1 North America Olanzapine Sales, Revenue and Market Share by Country 5.1.1 North America Olanzapine Sales and Market Share by Country (2014-2019) 5.1.2 North America Olanzapine Revenue and Market Share by Country (2014-2019) 5.2 United States Olanzapine Sales and Growth Rate (2014-2019) 5.3 Canada Olanzapine Sales and Growth Rate (2014-2019) 5.4 Mexico Olanzapine Sales and Growth Rate (2014-2019) 6 Europe Olanzapine by Country 6.1 Europe Olanzapine Sales, Revenue and Market Share by Country 6.1.1 Europe Olanzapine Sales and Market Share by Country (2014-2019) 6.1.2 Europe Olanzapine Revenue and Market Share by Country (2014-2019) 6.2 Germany Olanzapine Sales and Growth Rate (2014-2019) 6.3 UK Olanzapine Sales and Growth Rate (2014-2019) 6.4 France Olanzapine Sales and Growth Rate (2014-2019) 6.5 Russia Olanzapine Sales and Growth Rate (2014-2019) 6.6 Italy Olanzapine Sales and Growth Rate (2014-2019) 7 Asia-Pacific Olanzapine by Country 7.1 Asia-Pacific Olanzapine Sales, Revenue and Market Share by Country 7.1.1 Asia-Pacific Olanzapine Sales and Market Share by Country (2014-2019) 7.1.2 Asia-Pacific Olanzapine Revenue and Market Share by Country (2014-2019) 7.2 China Olanzapine Sales and Growth Rate (2014-2019) 7.3 Japan Olanzapine Sales and Growth Rate (2014-2019) 7.4 Korea Olanzapine Sales and Growth Rate (2014-2019) 7.5 India Olanzapine Sales and Growth Rate (2014-2019) 7.6 Southeast Asia Olanzapine Sales and Growth Rate (2014-2019) 8 South America Olanzapine by Country 8.1 South America Olanzapine Sales, Revenue and Market Share by Country 8.1.1 South America Olanzapine Sales and Market Share by Country (2014-2019) 8.1.2 South America Olanzapine Revenue and Market Share by Country (2014-2019) 8.2 Brazil Olanzapine Sales and Growth Rate (2014-2019) 8.3 Argentina Olanzapine Sales and Growth Rate (2014-2019) 8.4 Colombia Olanzapine Sales and Growth Rate (2014-2019) 9 Middle East and Africa Olanzapine by Countries 9.1 Middle East and Africa Olanzapine Sales, Revenue and Market Share by Country 9.1.1 Middle East and Africa Olanzapine Sales and Market Share by Country (2014-2019) 9.1.2 Middle East and Africa Olanzapine Revenue and Market Share by Country (2014-2019) 9.2 Saudi Arabia Olanzapine Sales and Growth Rate (2014-2019) 9.3 Turkey Olanzapine Sales and Growth Rate (2014-2019) 9.4 Egypt Olanzapine Sales and Growth Rate (2014-2019) 9.5 Nigeria Olanzapine Sales and Growth Rate (2014-2019) 9.6 South Africa Olanzapine Sales and Growth Rate (2014-2019) 10 Global Olanzapine Market Segment by Type 10.1 Global Olanzapine Sales, Revenue and Market Share by Type (2014-2019) 10.1.1 Global Olanzapine Sales and Market Share by Type (2014-2019) 10.1.2 Global Olanzapine Revenue and Market Share by Type (2014-2019) 10.2 Patent Type Sales Growth and Price 10.2.1 Global Patent Type Sales Growth (2014-2019) 10.2.2 Global Patent Type Price (2014-2019) 10.3 Generics Type Sales Growth and Price 10.3.1 Global Generics Type Sales Growth (2014-2019) 10.3.2 Global Generics Type Price (2014-2019) 11 Global Olanzapine Market Segment by Application 11.1 Global Olanzapine Sales Market Share by Application (2014-2019) 11.2 Olanzapine Tablets Sales Growth (2014-2019) 11.3 Other Medicine Sales Growth (2014-2019) 12 Olanzapine Market Forecast (2019-2024) 12.1 Global Olanzapine Sales, Revenue and Growth Rate (2019-2024) 12.2 Olanzapine Market Forecast by Regions (2019-2024) 12.2.1 North America Olanzapine Market Forecast (2019-2024) 12.2.2 Europe Olanzapine Market Forecast (2019-2024) 12.2.3 Asia-Pacific Olanzapine Market Forecast (2019-2024) 12.2.4 South America Olanzapine Market Forecast (2019-2024) 12.2.5 Middle East and Africa Olanzapine Market Forecast (2019-2024) 12.3 Olanzapine Market Forecast by Type (2019-2024) 12.3.1 Global Olanzapine Sales Forecast by Type (2019-2024) 12.3.2 Global Olanzapine Market Share Forecast by Type (2019-2024) 12.4 Olanzapine Market Forecast by Application (2019-2024) 12.4.1 Global Olanzapine Sales Forecast by Application (2019-2024) 12.4.2 Global Olanzapine Market Share Forecast by Application (2019-2024) 13 Sales Channel, Distributors, Traders and Dealers 13.1 Sales Channel 13.1.1 Direct Marketing 13.1.2 Indirect Marketing 13.1.3 Marketing Channel Future Trend 13.2 Distributors, Traders and Dealers 14 Research Findings and Conclusion 15 Appendix 15.1 Methodology 15.2 Data Source

Methodology

This research report involves complete picture of the market with the help of in-depth secondary and primary research. This research report studies several aspects of the market and analyze vital industry influencers. Extensive secondary research has been conducted using paid as well as open access data sources in order to gather information on the market and parent market. These key findings are then analyzed and validated with the help of in-house data models and primary discussions with key industry participants and experts across the value chain

research-methodology

Research Tools and Models

  • Top-Down Approach and Bottom-Up Approach
  • QFD Modeling for Market Size and Share Calculation
  • Regression, Variable and Impact Analysis
  • Penetration Modeling

Qualitative Research

  • It comprises briefing about market dynamics and business opportunities and strategies.
  • Finally, all the research findings are validated through interviews with in-house industry experts, freelance consultants and key opinion leaders etc.

Quantitative Research

It involves various mathematical tools, models, projection, and sampling techniques. It involves following steps:

  • Identification of market variables and market size derivation
  • Assessment of future prospects, opportunities and market penetration rates by analyzing product commercialization, regional trends etc.
  • Evaluation historical market trends and derivation of present and future year-on-year growth trends

Fill below details to get free sample !!

Contact Us
Call Now